AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Stone Disease of the Urinary Tract in Children

Recruitingn/aAges 1 Year - 17 YearsAllUniversity Hospital, Strasbourg, France
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The incidence of stone disease of the urinary tract in children is increasingly increasing with a remarkable economic impact for its management. This incidence is variable according to race, geographic region, socio-economic status and dietary habits. Oxalo-calcium stones are the most common but the biochemical nature of urinary stones varies depending on the region where those of a phosphatic nature are characterized by a higher incidence in Europe. The diagnosis is confirmed by imaging. The unprepared abdomen (ASP) has low diagnostic accuracy. The scanner is the reference tool but remains an irradiating examination. Risk factors for disease recurrence include primarily the presence of an underlying urinary metabolic abnormality and young age. Urinary metabolic abnormalities vary from one study to another. The understanding of lithogenesis, its evaluation as well as the therapeutic

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria: * Patients aged less than 18 years. * Both sexes. * Subjects presenting with lithiasis of the urinary tree in one of the two departments concerned between 01/01/2010 and 12/31/2022 * Subject not opposing, after information, the reuse of their data for the purposes of this research. * Holders of parental authority who do not object, after being informed, to the reuse of their child's data for the purposes of this research. Exclusion criteria: * Subject or holder of parental authority having expressed opposition to participating in the study. * Non-usable patient files: insufficient data.
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Service de Pรฉdiatrie 1 - CHU de Strasbourg - France
Strasbourg, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy